nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.08.2015 | Review Article

Hand Dermatitis: A Review of Clinical Features, Prevention and Treatment

verfasst von: Dimitar Antonov, Sibylle Schliemann, Peter Elsner

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Hand dermatitis is a socially significant health problem. This review provides a discussion on the clinical features and patterns as well as the differential diagnosis of hand dermatitis, because these are essential for proper diagnosis in clinical practice. The morphology, however, is poorly related to the etiology in chronic cases. In all cases of chronic hand dermatitis, a full diagnostic examination should be undertaken and the etiology should be clarified and addressed in the treatment concept, instead of just moving directly from a morphological diagnosis to therapy. Preventive measures should be included in the treatment concept according to etiology. A stepwise approach for escalating therapy is advised, including basic topical therapy, topical corticosteroids, calcineurin inhibitors, as well as phototherapy and systemic therapy with corticosteroids, alitretinoin, cyclosporine, methotrexate, azathioprine, and others.

Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, et al. Management of chronic hand eczema. Contact Dermatitis. 2007;57(4):203–10. doi:10.1111/j.1600-0536.2007.01179.x.PubMedCrossRef

Diepgen T, Elsner P, Schliemann S, Fartasch M, Köllner A, Skudlik C, et al. Management von Handekzemen Leitlinie ICD-10-Ziffer: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges. 2009;7(s3):s1–16.PubMed

Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown R, Homey B, et al. Redefining treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol. 2010;24(Suppl 3):1–20. doi:10.1111/j.1468-3083.2010.03615.x.PubMedCrossRef

Diepgen TL, Andersen KE, Chosidow O, Coenraads PJ, Elsner P, English J, et al. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges. 2015;13(1):e1–22.PubMedCrossRef

English J, Aldridge R, Gawkrodger DJ, Kownacki S, Statham B, White JM, et al. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol. 2009;34(7):761–9. doi:10.1111/j.1365-2230.2009.03649.x.PubMedCrossRef

Menne T, Johansen JD, Sommerlund M, Veien NK, Danish Contact Dermatitis G. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis. 2011;65(1):3–12. doi:10.1111/j.1600-0536.2011.01915.x.PubMedCrossRef

Elsner P, Schliemann S. Pitfalls and errors in patch testing: suggestions for quality assurance. In: Lachapelle JM, editor. Patch testing tips. Berlin: Springer; 2014. p. 27–35.CrossRef

Scalone L, Cortesi PA, Mantovani LG, Belisari A, Ayala F, Fortina AB, et al. Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy. Br J Dermatol. 2015;172(1):187–95. doi:10.1111/bjd.13220.PubMedCrossRef

Malten KE. Thoughts on irritant contact dermatitis. Contact Dermatitis. 1981;7(5):238–47.PubMedCrossRef

10.

Freeman S, Maibach H. Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry. J Am Acad Dermatol. 1988;19(3):496–502.PubMedCrossRef

11.

Ruppert L, Apfelbacher C, Molin S, Bauer A, Mahler V, Schmitt J, et al. Itching in patients with chronic hand eczema: data from the CARPE registry. Dermatology. 2014;229(2):146–53. doi:10.1159/000362901.PubMedCrossRef

12.

Johansen JD, Hald M, Andersen BL, Laurberg G, Danielsen A, Avnstorp C, et al. Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis. 2011;65(1):13–21. doi:10.1111/j.1600-0536.2011.01911.x.PubMedCrossRef

13.

Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruynzeel DP, Frosch P, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol. 2009;160(2):353–8. doi:10.1111/j.1365-2133.2008.08907.x.PubMedCrossRef

14.

Molin S, Diepgen TL, Ruzicka T, Prinz JC. Diagnosing chronic hand eczema by an algorithm: a tool for classification in clinical practice. Clin Exp Dermatol. 2011;36(6):595–601. doi:10.1111/j.1365-2230.2010.04001.x.PubMedCrossRef

15.

Kutzner H, Wurzel RM, Wolff HH. Are acrosyringia involved in the pathogenesis of “dyshidrosis”? Am J Dermatopathol. 1986;8(2):109–16.PubMedCrossRef

16.

Lee WJ, Lee DW, Kim CH, Won CH, Chang SE, Lee MW, et al. Pompholyx with bile-coloured vesicles in a patient with jaundice: are sweat ducts involved in the development of pompholyx? J Eur Acad Dermatol Venereol. 2010;24(2):235–6. doi:10.1111/j.1468-3083.2009.03383.x.PubMedCrossRef

17.

Resnik KS, Kantor GR, Lessin SR, Kadin ME, Chooback L, Cooper HS, et al. Mycosis fungoides palmaris et plantaris. Arch Dermatol. 1995;131(9):1052–6.PubMedCrossRef

18.

Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18(4):397–415. doi:10.1111/j.1468-3083.2004.00937.x.PubMedCrossRef

19.

Wollina U. Pompholyx: what’s new? Expert Opin Investig Drugs. 2008;17(6):897–904. doi:10.1517/13543784.17.6.897.PubMedCrossRef

20.

Held E, Mygind K, Wolff C, Gyntelberg F, Agner T. Prevention of work related skin problems: an intervention study in wet work employees. Occup Environ Med. 2002;59(8):556–61.PubMedCentralPubMedCrossRef

21.

Jungbauer FH, van der Harst JJ, Groothoff JW, Coenraads PJ. Skin protection in nursing work: promoting the use of gloves and hand alcohol. Contact Dermatitis. 2004;51(3):135–40.PubMedCrossRef

22.

Flyvholm MA, Mygind K, Sell L, Jensen A, Jepsen KF. A randomised controlled intervention study on prevention of work related skin problems among gut cleaners in swine slaughterhouses. Occup Environ Med. 2005;62(9):642–9. doi:10.1136/oem.2004.016576.PubMedCentralPubMedCrossRef

23.

Weisshaar E, Radulescu M, Bock M, Albrecht U, Diepgen TL. Educational and dermatological aspects of secondary individual prevention in healthcare workers. Contact Dermatitis. 2006;54(5):254–60.PubMedCrossRef

24.

Seyfarth F, Schliemann S, Antonov D, Elsner P. Teaching interventions in contact dermatitis. Dermatitis. 2011;22(1):8–15.PubMed

25.

Slotosch CM, Kampf G, Loffler H. Effects of disinfectants and detergents on skin irritation. Contact Dermatitis. 2007;57(4):235–41. doi:10.1111/j.1600-0536.2007.01200.x.PubMedCrossRef

26.

Kappes UP, Goritz N, Wigger-Alberti W, Heinemann C, Elsner P. Tandem application of sodium lauryl sulfate and n-propanol does not lead to enhancement of cumulative skin irritation. Acta Derm Venereol. 2001;81(6):403–5.PubMedCrossRef

27.

Yokota M, Maibach HI. Moisturizer effect on irritant dermatitis: an overview. Contact Dermatitis. 2006;55(2):65–72. doi:10.1111/j.0105-1873.2006.00890.x.PubMedCrossRef

28.

Bourke J, Coulson I, English J. Guidelines for the management of contact dermatitis: an update. Br J Dermatol. 2009;160(5):946–54. doi:10.1111/j.1365-2133.2009.09106.x.PubMedCrossRef

29.

Kutting B, Baumeister T, Weistenhofer W, Pfahlberg A, Uter W, Drexler H. Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year. Br J Dermatol. 2009. doi:10.1111/j.1365-2133.2009.09485.x.

30.

Fartasch M, Diepgen TL, Drexler H, Elsner P, Fluhr JW, John SM, et al. Berufliche Hautmittel. 2008. http://www.awmf.org/uploads/tx_szleitlinien/013-056l_S1_Berufliche_Hautmittel_2008.pdf. Accessed 29 Nov 2014.

31.

Van Coevorden AM, Coenraads PJ, Svensson A, Bavinck JN, Diepgen TL, Naldi L, et al. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol. 2004;151(2):446–51. doi:10.1111/j.1365-2133.2004.06040.x.PubMedCrossRef

32.

De Paepe K, Hachem JP, Vanpee E, Goossens A, Germaux MA, Lachapelle JM, et al. Beneficial effects of a skin tolerance-tested moisturizing cream on the barrier function in experimentally-elicited irritant and allergic contact dermatitis. Contact Dermatitis. 2001;44(6):337–43 (cod440604 [pii]).PubMedCrossRef

33.

Ramsing DW, Agner T. Preventive and therapeutic effects of a moisturizer. An experimental study of human skin. Acta Derm Venereol. 1997;77(5):335–7.PubMed

34.

Loden M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol. 2005;19(6):672–88. doi:10.1111/j.1468-3083.2005.01326.x (quiz 86–7).PubMedCrossRef

35.

Folster-Holst R, Latussek E. Synthetic tannins in dermatology—a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol. 2007;24(3):296–301. doi:10.1111/j.1525-1470.2007.00406.x.PubMedCrossRef

36.

Nilsson E, Henning C, Hjorleifsson ML. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol. 1986;15(2 Pt 1):192–7.PubMedCrossRef

37.

Frosch PJ, Schulze-Dirks A. Contact allergy caused by polidocanol (thesit). Hautarzt. 1989;40(3):146–9.PubMed

38.

Uter W, Geier J, Fuchs T. Contact allergy to polidocanol, 1992 to 1999. J Allergy Clin Immunol. 2000;106(6):1203–4 (S0091674900870852 [pii]).PubMedCrossRef

39.

Veenhuis RT, van Horssen J, Bos RP, Anzion RB, Van Der Valk PG. Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar. Arch Dermatol Res. 2002;294(4):168–71. doi:10.1007/s00403-002-0311-5.PubMedCrossRef

40.

Luger T, Loske KD, Elsner P, Kapp A, Kerscher M, Korting HC, et al. Topical skin therapy with glucocorticoids–therapeutic index. J Dtsch Dermatol Ges. 2004;2(7):629–34.PubMedCrossRef

41.

Luger T, Elsner P, Kerscher M, Korting HC, Krutmann J, Niedner R, et al. Topische Dermatotherapie mit Glukokortikoiden—Therapeutischer Index. ICD 10: L20. In: Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG). Düsseldorf. 2009. http://www.derma.de/fileadmin/derma/pdfs/ll_glukokortikoide.pdf. Accessed 29 Nov 2014.

42.

Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol. 1999;140(5):882–6 (bjd2819 [pii]).PubMedCrossRef

43.

Hachem JP, De Paepe K, Vanpee E, Kaufman L, Rogiers V, Roseeuw D. Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements. Dermatology. 2001;202(4):314–9 (drm02314 [pii]).PubMedCrossRef

44.

Corticosteroids Isaksson M. Dermatol Ther. 2004;17(4):314–20. doi:10.1111/j.1396-0296.2004.04036.x.CrossRef

45.

Isaksson M, Bruze M. Repetitive usage testing with budesonide in experimental nickel–allergic contact dermatitis in individuals hypersensitive to budesonide. Br J Dermatol. 2001;145(1):38–44 (bjd4279 [pii]).PubMedCrossRef

46.

Uter W, de Padua CM, Pfahlberg A, Nink K, Schnuch A, Lessmann H. Contact allergy to topical corticosteroids–results from the IVDK and epidemiological risk assessment. J Dtsch Dermatol Ges. 2009;7(1):34–41, 34–42. doi:10.1111/j.1610-0387.2008.06844.x.

47.

Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology. 2007;215(Suppl 1):45–54. doi:10.1159/000102119.PubMedCrossRef

48.

Schliemann S, Kelterer D, Bauer A, John SM, Skudlik C, Schindera I, et al. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis. 2008;58(5):299–306. doi:10.1111/j.1600-0536.2007.01314.x.PubMedCrossRef

49.

Queille-Roussel C, Graeber M, Thurston M, Lachapelle JM, Decroix J, de Cuyper C, et al. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatitis. 2000;42(6):349–50.PubMedCrossRef

50.

Thelmo MC, Lang W, Brooke E, Osborne BE, McCarty MA, Jorizzo JL, et al. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatol Treat. 2003;14(3):136–40 (ECGNGAJB45URRKDW [pii]).CrossRef

51.

Ring J, Barker J, Behrendt H, Braathen L, Darsow U, Dubertret L, et al. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol. 2005;19(6):663–71. doi:10.1111/j.1468-3083.2005.01315.x.PubMedCrossRef

52.

Belsito DV, Fowler JF Jr, Marks JG Jr, Pariser DM, Hanifin J, Duarte IA, et al. Pimecrolimus cream 1 %: a potential new treatment for chronic hand dermatitis. Cutis. 2004;73(1):31–8.PubMed

53.

Margolis DJ, Abuabara K, Hoffstad OJ, Wan J, Raimondo D, Bilker WB. Association between malignancy and topical use of pimecrolimus. JAMA Dermatol. 2015. doi:10.1001/jamadermatol.2014.4305.

54.

Wollenberg A, Frank R, Kroth J, Ruzicka T. Proactive therapy of atopic eczema–an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges. 2009;7(2):117–21. doi:10.1111/j.1610-0387.2008.06772.x.PubMed

55.

Bauer A, Lange N, Matterne U, Meurer M, Braeutigam M, Diepgen TL. Efficacy of pimecrolimus 1 % cream in the long term management of atopic hand dermatitis. A double-blind RCT. J Dtsch Dermatol Ges. 2012;10(6):426–33. doi:10.1111/j.1610-0387.2011.07832.x.PubMed

56.

Brasch J, Becker D, Aberer W, Bircher A, Kranke B, Denzer-Furst S, et al. Contact dermatitis. J Dtsch Dermatol Ges. 2007;5(10):943–51. doi:10.1111/j.1610-0387.2007.06523.x.PubMedCrossRef

57.

Jensen L, Stensgaard A, Andersen KE. Psoralen plus ultraviolet A (PUVA) soaks and UVB TL01 treatment for chronic hand dermatoses. Dermatol Rep. 2012;4(1):e3. doi:10.4081/dr.2012.e3.CrossRef

58.

Hölzle E, Gollnick H, Herzinger T, Hönigsmann H, Lehmann P, Meffert H, et al. Empfehlungen zur Phototherapie und Photochemotherapie. 2002. http://www.awmf.org/uploads/tx_szleitlinien/013-029-abgelaufen.pdf. Accessed 29 Nov 2014.

59.

Schempp CM, Muller H, Czech W, Schopf E, Simon JC. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol. 1997;36(5 Pt 1):733–7 (S0190-9622(97)80326-X [pii]).PubMedCrossRef

60.

Behrens S, von Kobyletzki G, Gruss C, Reuther T, Altmeyer P, Kerscher M. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed. 1999;15(2):47–51.PubMedCrossRef

61.

Stege H, Berneburg M, Ruzicka T, Krutmann J. Cream PUVA photochemotherapy. Hautarzt. 1997;48(2):89–93.PubMedCrossRef

62.

Polderman MC, Govaert JC, le Cessie S, Pavel S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol. 2003;28(6):584–7 (1378 [pii]).PubMedCrossRef

63.

Petering H, Breuer C, Herbst R, Kapp A, Werfel T. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol. 2004;50(1):68–72. doi:10.1016/S0190.PubMedCrossRef

64.

Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol. 1998;78(4):318–9.PubMedCrossRef

65.

Stege H. Ultraviolet therapy in patients with chronic hand eczema. Hautarzt. 2008;59(9):696–702. doi:10.1007/s00105-008-1558-3.PubMedCrossRef

66.

van Coevorden AM, Kamphof WG, van Sonderen E, Bruynzeel DP, Coenraads PJ. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol. 2004;140(12):1463–6. doi:10.1001/archderm.140.12.1463.PubMed

67.

Bayerl C, Gabea A, Peiler D, Rzany B, Allgäuer T, Kleesz P, et al. Pilotstudie zur Therapie des beruflich bedingten Handekzems mit einer neuen tragbaren UVB-Bestralungseinheit. Aktuelle Derm. 1999;25:302–5.

68.

Fairris GM, Jones DH, Mack DP, Rowell NR. Superficial X-ray therapy in the treatment of constitutional eczema of the feet. Br J Dermatol. 1984;111(4):500–2.PubMedCrossRef

69.

Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis. 2006;17(4):165–81.PubMedCrossRef

70.

NICE. Grenz rays therapy for inflammatory skin conditions. 2007. http://guidance.nice.org.uk/IPG236. Accessed 29 Nov 2014.

71.

Warner JA, Cruz PD Jr. Grenz ray therapy in the new millennium: still a valid treatment option? Dermatitis. 2008;19(2):73–80.PubMed

72.

Fairris GM, Jones DH, Mack DP, Rowell NR. Conventional superficial X-ray versus Grenz ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol. 1985;112(3):339–41.PubMedCrossRef

73.

Bollag W, Ott F. Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid. Dermatology. 1999;199(4):308–12 (drm99308 [pii]).PubMedCrossRef

74.

Cheng C, Michaels J, Scheinfeld N. Alitretinoin: a comprehensive review. Expert Opin Investig Drugs. 2008;17(3):437–43. doi:10.1517/13543784.17.3.437.PubMedCrossRef

75.

Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158(4):808–17. doi:10.1111/j.1365-2133.2008.08487.x.PubMedCrossRef

76.

Reymann F. Two years’ experience with Tigason treatment of pustulosis palmo-plantaris and eczema keratoticum manuum. Dermatologica. 1982;164(3):209–16.PubMedCrossRef

77.

Hanifin JM, Stevens V, Sheth P, Breneman D. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol. 2004;150(3):545–53. doi:10.1046/j.1365-2133.2003.05729.x.PubMedCrossRef

78.

Thestrup-Pedersen K, Andersen KE, Menne T, Veien NK. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol. 2001;81(5):353–5.PubMedCrossRef

79.

Reitamo S, Granlund H. Cyclosporin A in the treatment of chronic dermatitis of the hands. Br J Dermatol. 1994;130(1):75–8.PubMedCrossRef

80.

Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76(5):371–6.PubMed

81.

Mrowietz U, Eberhard Klein C, Reich K, Rosenbach T, Ruzicka T, Sebastian M, et al. Therapie mit Ciclosporin in der Dermatologie. 2000. http://www.derma.de/fileadmin/derma/pdfs/ll_ciclosporin.pdf. Accessed 29 Nov 2014.

82.

Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema—a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21(5):606–19. doi:10.1111/j.1468-3083.2006.02023.x.PubMed

83.

Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet. 2001;358(9287):1042–5. doi:10.1016/S0140-6736(01)06179-7.PubMedCrossRef

84.

Vakeva L, Reitamo S, Pukkala E, Sarna S, Ranki A. Long-term follow-up of cancer risk in patients treated with short-term cyclosporine. Acta Derm Venereol. 2008;88(2):117–20. doi:10.2340/00015555-0360.PubMedCrossRef

85.

Verma KK, Mahesh R, Srivastava P, Ramam M, Mukhopadhyaya AK. Azathioprine versus betamethasone for the treatment of parthenium dermatitis: a randomized controlled study. Indian J Dermatol Venereol Leprol. 2008;74(5):453–7.PubMedCrossRef

86.

Verma KK, Bansal A, Sethuraman G. Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol. 2006;72(1):24–7.PubMedCrossRef

87.

Wise M, Callen JP. Azathioprine: a guide for the management of dermatology patients. Dermatol Ther. 2007;20(4):206–15. doi:10.1111/j.1529-8019.2007.00134.x.PubMedCrossRef

88.

Anstey AV, Wakelin S, Reynolds NJ. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol. 2004;151(6):1123–32. doi:10.1111/j.1365-2133.2004.06323.x.PubMedCrossRef

89.

Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 1999;40(4):612–4 (S0190-9622(99)70446-9 [pii]).PubMedCrossRef

90.

Shaffrali FC, Colver GB, Messenger AG, Gawkrodger DJ. Experience with low-dose methotrexate for the treatment of eczema in the elderly. J Am Acad Dermatol. 2003;48(3):417–9. doi:10.1067/mjd.2003.137.PubMedCrossRef

91.

Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol. 1998;134(3):378–9.PubMedCrossRef

92.

Bagot M, Terki N, Bacha S, Moyse D, Suck C, Revuz J. Per os desensitization in nickel contact eczema: a double-blind placebo-controlled clinico-biological study. Ann Dermatol Venereol. 1999;126(6–7):502–4 (MDOI-AD-06-1999-126-6-7-0151-9638-101019-ART4 [pii]).PubMed

93.

Handa S, Sahoo B, Sharma VK. Oral hyposensitization in patients with contact dermatitis from Parthenium hysterophorus. Contact Dermatitis. 2001;44(5):279–82 (cod440505 [pii]).PubMedCrossRef

94.

Sharma AD. Relationship between nickel allergy and diet. Indian J Dermatol Venereol Leprol. 2007;73(5):307–12.PubMedCrossRef

95.

Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–72.PubMedCrossRef

96.

Weisshaar E, Kallen U, Weiss M. “The itching hand”—important differential diagnoses and treatment. J Dtsch Dermatol Ges. 2013;11(1):31–42. doi:10.1111/j.1610-0387.2012.08002.x.PubMed

Titel: Hand Dermatitis: A Review of Clinical Features, Prevention and Treatment
verfasst von: Dimitar Antonov
Sibylle Schliemann
Peter Elsner
Publikationsdatum: 01.08.2015
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 4/2015
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-015-0130-z

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

16.04.2024 | Infektiologie | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Hand Dermatitis: A Review of Clinical Features, Prevention and Treatment

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Dupilumab ist mit kutanen T-Zell-Lymphomen assoziiert

Chemotherapie mit Hindernissen

Update Dermatologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Cellulite: An Evidence-Based Review

Immunogenicity of Biologic Treatments for Psoriasis: Therapeutic Consequences and the Potential Value of Concomitant Methotrexate

Comment on: Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation

Reply to Frane: Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation

Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria

Dermal Fillers: An Update

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Dupilumab ist mit kutanen T-Zell-Lymphomen assoziiert

Chemotherapie mit Hindernissen

Update Dermatologie